JP2025527471A5 - - Google Patents

Info

Publication number
JP2025527471A5
JP2025527471A5 JP2025508431A JP2025508431A JP2025527471A5 JP 2025527471 A5 JP2025527471 A5 JP 2025527471A5 JP 2025508431 A JP2025508431 A JP 2025508431A JP 2025508431 A JP2025508431 A JP 2025508431A JP 2025527471 A5 JP2025527471 A5 JP 2025527471A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
caprate
crystalline form
therapeutically effective
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025508431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025527471A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/072326 external-priority patent/WO2024040125A1/en
Publication of JP2025527471A publication Critical patent/JP2025527471A/ja
Publication of JP2025527471A5 publication Critical patent/JP2025527471A5/ja
Pending legal-status Critical Current

Links

JP2025508431A 2022-08-17 2023-08-16 Pcsk9阻害薬の結晶形態、組成物及び使用 Pending JP2025527471A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263371690P 2022-08-17 2022-08-17
US63/371,690 2022-08-17
US202263384298P 2022-11-18 2022-11-18
US63/384,298 2022-11-18
PCT/US2023/072326 WO2024040125A1 (en) 2022-08-17 2023-08-16 Crystalline forms of a pcsk9 inhibitor, compositions and uses

Publications (2)

Publication Number Publication Date
JP2025527471A JP2025527471A (ja) 2025-08-22
JP2025527471A5 true JP2025527471A5 (https=) 2025-12-23

Family

ID=89942405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025508431A Pending JP2025527471A (ja) 2022-08-17 2023-08-16 Pcsk9阻害薬の結晶形態、組成物及び使用

Country Status (10)

Country Link
US (1) US20260035411A1 (https=)
EP (1) EP4573104A1 (https=)
JP (1) JP2025527471A (https=)
KR (1) KR20250048468A (https=)
CN (1) CN119731194A (https=)
AU (1) AU2023325144A1 (https=)
CO (1) CO2025001998A2 (https=)
IL (1) IL319006A (https=)
MX (1) MX2025001887A (https=)
WO (1) WO2024040125A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026032253A1 (zh) * 2024-08-06 2026-02-12 石药集团中奇制药技术(石家庄)有限公司 环肽类似物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019246405A1 (en) * 2018-06-21 2019-12-26 Merck Sharp & Dohme Corp. Cyclic polypeptides for pcsk9 inhibition
US11306125B2 (en) * 2018-06-21 2022-04-19 Merck Sharp & Dohme Corp. PCSK9 antagonists bicyclo-compounds
IL279363B2 (en) * 2018-06-21 2025-12-01 Merck Sharp & Dohme Pcsk9 antagonist compounds
EP4021919A1 (en) * 2019-08-30 2022-07-06 Merck Sharp & Dohme Corp. Pcsk9 antagonist compounds

Similar Documents

Publication Publication Date Title
JP7660600B2 (ja) 慢性炎症性疾患および/または自己免疫疾患の予防または治療における使用のためのビドフルジムス(Vidofludimus)の投与レジメン
JP3305315B2 (ja) 動物及び人間の疼痛及び/又は炎症の抑制時における薬剤ならびにその製造及びその使用
FI119722B (fi) Valasikloviiritabletteja, jotka sisältävät kolloidista silikonidioksidia
JP2022536979A5 (https=)
AU2020234929B2 (en) Formulations of a compound and uses thereof
CN102395276A (zh) 硝唑尼特的控制释放药物剂型
JP2006516570A5 (https=)
JP2024540183A5 (https=)
EP0989848A2 (en) Film-coated tablet for improved upper gastrointestinal tract safety
JP6855488B2 (ja) 食道癌を治療するためのキノリン誘導体の使用とその治療方法、医薬組成物及びキット
HU228149B1 (en) Film coated tablet of paracetamol and domperidone
JP2008533127A5 (https=)
JP2024544538A5 (https=)
JP2025527471A5 (https=)
JP2019218379A5 (https=)
JP7774958B2 (ja) 二層医薬錠剤製剤
JP2024045113A5 (https=)
CN101296696A (zh) 一种用于治疗痛风的药物组合物及其制备方法和用途
JP2022532540A (ja) アキシチニブを含有する医薬組成物
JP2022518288A5 (https=)
JP3982889B2 (ja) イブプロフェン含有医薬製剤
KR102022694B1 (ko) 약학 조성물
WO2020089761A1 (en) Pharmaceutical composition comprising of remogliflozin or salt or ester thereof and vildagliptin or salt thereof
JP4153124B2 (ja) 鎮痛剤
JP6197515B2 (ja) 医薬組成物